JPWO2024014524A1 - - Google Patents

Info

Publication number
JPWO2024014524A1
JPWO2024014524A1 JP2024533757A JP2024533757A JPWO2024014524A1 JP WO2024014524 A1 JPWO2024014524 A1 JP WO2024014524A1 JP 2024533757 A JP2024533757 A JP 2024533757A JP 2024533757 A JP2024533757 A JP 2024533757A JP WO2024014524 A1 JPWO2024014524 A1 JP WO2024014524A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024533757A
Other languages
Japanese (ja)
Other versions
JPWO2024014524A5 (cg-RX-API-DMAC7.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2024014524A1 publication Critical patent/JPWO2024014524A1/ja
Publication of JPWO2024014524A5 publication Critical patent/JPWO2024014524A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2024533757A 2022-07-15 2023-07-14 Pending JPWO2024014524A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022113930 2022-07-15
PCT/JP2023/025980 WO2024014524A1 (ja) 2022-07-15 2023-07-14 血中ldlコレステロール低下剤

Publications (2)

Publication Number Publication Date
JPWO2024014524A1 true JPWO2024014524A1 (cg-RX-API-DMAC7.html) 2024-01-18
JPWO2024014524A5 JPWO2024014524A5 (cg-RX-API-DMAC7.html) 2026-06-23

Family

ID=89536850

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024533757A Pending JPWO2024014524A1 (cg-RX-API-DMAC7.html) 2022-07-15 2023-07-14

Country Status (8)

Country Link
US (1) US20260014122A1 (cg-RX-API-DMAC7.html)
EP (1) EP4556006A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2024014524A1 (cg-RX-API-DMAC7.html)
KR (1) KR20250034041A (cg-RX-API-DMAC7.html)
CN (1) CN119546300A (cg-RX-API-DMAC7.html)
JO (1) JOP20250007A1 (cg-RX-API-DMAC7.html)
TW (1) TW202408500A (cg-RX-API-DMAC7.html)
WO (1) WO2024014524A1 (cg-RX-API-DMAC7.html)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015005365A1 (ja) * 2013-07-10 2015-01-15 興和株式会社 非アルコール性脂肪性肝疾患治療剤
US20180028505A1 (en) * 2016-07-29 2018-02-01 Kowa Company, Ltd. Methods of Preventing Cardiovascular Events in Residual Risk Dyslipidemic Populations
JP2021506907A (ja) * 2017-12-21 2021-02-22 興和株式会社 高トリグリセライド血症の治療方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20110009T1 (hr) 2003-09-03 2011-03-31 Kowa Co. Spoj kojim se aktivira ppar i farmaceutski pripravak koji ga sadrži
US11446282B2 (en) * 2017-12-21 2022-09-20 Kowa Company, Ltd. Methods of treating mixed dyslipidemia and hypertriglycertdemia
EP4346809B1 (en) * 2021-05-27 2026-07-15 Kowa Company, Ltd. Pemafibrate for use in treating liver disease

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015005365A1 (ja) * 2013-07-10 2015-01-15 興和株式会社 非アルコール性脂肪性肝疾患治療剤
US20180028505A1 (en) * 2016-07-29 2018-02-01 Kowa Company, Ltd. Methods of Preventing Cardiovascular Events in Residual Risk Dyslipidemic Populations
JP2021506907A (ja) * 2017-12-21 2021-02-22 興和株式会社 高トリグリセライド血症の治療方法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ALIMENT. PHARMACOL. THER., vol. 54, JPN6023038995, 2021, pages 1263 - 1277, ISSN: 0005897878 *
INTERN. MED., vol. 60, JPN6023038996, 2021, pages 2741 - 2748, ISSN: 0005897881 *
JOURNAL OF CLINICAL LIPIDOLOGY, vol. 12, JPN6023038993, 2018, pages 173 - 184, ISSN: 0005897879 *
SCIENTIFIC REPORTS, vol. 10:7818, JPN6023038992, 2020, pages 1 - 10, ISSN: 0005897882 *
生物試料分析, vol. Vol.41(5), JPN6023038994, 2018, pages 217 - 221, ISSN: 0005897880 *

Also Published As

Publication number Publication date
EP4556006A1 (en) 2025-05-21
KR20250034041A (ko) 2025-03-10
JOP20250007A1 (ar) 2025-01-13
EP4556006A4 (en) 2026-01-07
CN119546300A (zh) 2025-02-28
TW202408500A (zh) 2024-03-01
US20260014122A1 (en) 2026-01-15
WO2024014524A1 (ja) 2024-01-18

Similar Documents

Publication Publication Date Title
BR102023005164A2 (cg-RX-API-DMAC7.html)
BR102022025291A2 (cg-RX-API-DMAC7.html)
BR112025020304B1 (pt) Liga de solda, esfera de solda, pré-forma de solda, junta de solda e circuito
BR112025024041B1 (pt) Elemento de despejamento para uma embalagem compósita e embalagem compósita com um elemento de despejamento
BR112025008516B1 (pt) Método tudo em um de recuperação de níquel para recuperar níquel a partir de matérias-primas contendo níquel
BR112025016688B1 (pt) Compostos e composições farmacêuticas
BR112025011041B1 (pt) Dispositivo para inspeção de um elemento roscado e método de inspeção correspondente
BR112024022558B1 (pt) Polipeptídeo, polinucleotídeo, ácido nucleico, vetor, célula hospedeira, método para produzir o polipeptídeo, composição, e, método in vitro para aumentar adesão celular
BR112025005915B1 (pt) Gerador, dispositivo e método de ablação de campo pulsado
BR102023016405B1 (pt) Estrutura de viga de pá, pá de energia eólica e equipamento de energia eólica
BR112024026850B1 (pt) Triturador de mandíbula e método de serviço ou de manutenção de um triturador de mandíbula
BR112024025233B1 (pt) Método para alterar o estado de elevação vertical para um veículo transportador, controle e veículo
BR102023009702B1 (pt) Dispositivo para alisamento e aplicação de substância de tratamento
BR112024027500B1 (pt) Polipeptídeo, ácido nucleico, vetor, célula hospedeira, método para produzir o polipeptídeo, composição, uso do polipeptídeo, e, método para promover a proliferação de uma célula in vitro
BR102023002997B1 (pt) Um aparelho para detecção de vazamento de um gás e um método e um sistema do mesmo
BR112024018530B1 (pt) Método para determinar nível de escória do alto-forno, método para operar alto-forno e unidade de controle
BR112024027130B1 (pt) Sistema e método para um conjunto de cuff (balão) de tubo endotraqueal
BR112025001284B1 (pt) Cabo, sistema de sensor e método de montagem de um alojamento de sensor
BR102022024748B1 (pt) Equipamento extrator de esporos da superfície de grãos de cereal para aplicação em laboratório e seu processo operacional
BR122025008970A2 (pt) Método para decodificar um vídeo, sistema e mídia legível por computador
BR122025008972A2 (pt) Sistema, método para decodificar um vídeo e mídia legível por computador
BR122025008973A2 (pt) Sistema, método para decodificar um vídeo e mídia legível por computador
BR102022009310B1 (pt) Sistema de montagem para as linhas de adubo de implementos agrícolas
BR112023000644B1 (pt) Dispositivos vestíveis
BR102022000201B1 (pt) Processo de revestimento, espuma polimérica e processo de sorção

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260615

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260615

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20260615

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260630